$298 Million is the total value of Sio Capital Management, LLC's 69 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 104.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | New | AMGEN INC | $21,503,000 | – | 106,069 | +100.0% | 7.21% | – |
| MCK | Buy | MCKESSON CORP | $17,900,000 | +89.1% | 132,340 | +93.4% | 6.00% | +166.0% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $17,483,000 | +2.6% | 1,077,839 | +13.8% | 5.86% | +44.3% |
| CVM | Sell | CEL-SCI CORPput | $15,038,000 | +7.6% | 1,303,100 | -14.7% | 5.04% | +51.4% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $14,716,000 | -24.2% | 168,044 | -9.5% | 4.93% | +6.6% |
| BIIB | New | BIOGEN INC | $13,268,000 | – | 41,938 | +100.0% | 4.45% | – |
| ANTM | Buy | ANTHEM INC | $13,139,000 | +41.5% | 57,869 | +88.3% | 4.40% | +99.2% |
| BSX | New | BOSTON SCIENTIFIC CORP | $12,913,000 | – | 395,747 | +100.0% | 4.33% | – |
| NVST | New | ENVISTA HOLDINGS CORP | $12,802,000 | – | 856,922 | +100.0% | 4.29% | – |
| AGN | Sell | ALLERGAN PLC | $9,741,000 | -47.4% | 55,000 | -43.3% | 3.26% | -26.0% |
| GLD | New | SPDR GOLD SHARES | $9,579,000 | – | 64,702 | +100.0% | 3.21% | – |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $8,612,000 | -26.3% | 90,823 | -31.5% | 2.89% | +3.7% |
| BMYRT | New | BRISTOL-MYERS SQUIBB COright | $8,538,000 | – | 2,246,900 | +100.0% | 2.86% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $7,472,000 | – | 721,193 | +100.0% | 2.50% | – |
| MRK | Sell | MERCK & CO INC | $7,162,000 | -53.6% | 93,083 | -45.2% | 2.40% | -34.7% |
| HCA | Sell | HCA HEALTHCARE INC | $7,002,000 | -56.8% | 77,932 | -28.9% | 2.35% | -39.2% |
| IMAB | New | I-MABsponsored ads | $6,145,000 | – | 472,675 | +100.0% | 2.06% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $5,461,000 | – | 21,900 | +100.0% | 1.83% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDUSTRIES LTDsponsored ads | $5,143,000 | – | 572,681 | +100.0% | 1.72% | – |
| RDUS | Buy | RADIUS HEALTH INC | $5,036,000 | +149.8% | 387,402 | +287.4% | 1.69% | +251.7% |
| MOH | Sell | MOLINA HEALTHCARE INC | $5,026,000 | -49.4% | 35,973 | -50.9% | 1.68% | -28.9% |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $4,751,000 | – | 47,000 | +100.0% | 1.59% | – |
| QTRX | New | QUANTERIX CORP | $4,355,000 | – | 237,081 | +100.0% | 1.46% | – |
| MEIP | Buy | MEI PHARMA INC | $4,001,000 | -32.7% | 2,485,098 | +3.6% | 1.34% | -5.4% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $3,576,000 | -11.9% | 85,153 | -4.7% | 1.20% | +23.9% |
| ARDX | ARDELYX INC | $3,533,000 | -24.3% | 621,534 | 0.0% | 1.18% | +6.6% | |
| VKTX | Buy | VIKING THERAPEUTICS INC | $3,520,000 | -40.0% | 752,241 | +2.8% | 1.18% | -15.5% |
| WBA | New | WALGREENS BOOTS ALLIANCE INCcall | $3,175,000 | – | 69,400 | +100.0% | 1.06% | – |
| SYNH | Buy | SYNEOS HEALTH INCcl a | $3,041,000 | -4.1% | 77,131 | +44.7% | 1.02% | +35.0% |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $2,778,000 | -10.4% | 468,532 | +4.5% | 0.93% | +26.2% |
| ESPR | Buy | ESPERION THERAPEUTICS INC | $2,541,000 | -24.8% | 80,600 | +42.3% | 0.85% | +5.8% |
| ALKS | New | ALKERMES PLC | $2,452,000 | – | 170,042 | +100.0% | 0.82% | – |
| LSACU | New | LIFESCI ACQUISITION CORPunit 03/31/2025 | $2,100,000 | – | 210,000 | +100.0% | 0.70% | – |
| MD | New | MEDNAX INC | $2,057,000 | – | 176,690 | +100.0% | 0.69% | – |
| OSMT | New | OSMOTICA PHARMACEUTICALS PLC | $1,829,000 | – | 575,000 | +100.0% | 0.61% | – |
| ZFGN | Buy | ZAFGEN INC | $1,796,000 | -29.1% | 2,332,164 | +2.1% | 0.60% | -0.3% |
| IMVT | Sell | IMMUNOVANT INC | $1,776,000 | -67.6% | 114,133 | -81.5% | 0.60% | -54.4% |
| LPTX | Buy | LEAP THERAPEUTICS INC | $1,737,000 | +225.9% | 1,099,542 | +130.9% | 0.58% | +358.3% |
| Sell | TRILLIUM THERAPEUTICS INC | $1,687,000 | -40.5% | 417,577 | -84.8% | 0.56% | -16.3% | |
| AFMD | AFFIMED NV | $1,609,000 | -42.3% | 1,018,200 | 0.0% | 0.54% | -18.9% | |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $1,564,000 | – | 13,889 | +100.0% | 0.52% | – |
| HQY | New | HEALTHEQUITY INC | $1,553,000 | – | 30,700 | +100.0% | 0.52% | – |
| MEDP | Sell | MEDPACE HOLDINGS INC | $1,531,000 | -31.5% | 20,858 | -21.6% | 0.51% | -3.8% |
| KDMN | New | KADMON HOLDINGS INC | $1,414,000 | – | 337,500 | +100.0% | 0.47% | – |
| ABC | Sell | AMERISOURCEBERGEN CORP | $1,410,000 | -85.1% | 15,928 | -85.7% | 0.47% | -79.0% |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $1,321,000 | -36.1% | 1,294,911 | +27.2% | 0.44% | -10.0% |
| VSTM | New | VERASTEM INC | $1,299,000 | – | 492,085 | +100.0% | 0.44% | – |
| HROW | Sell | HARROW HEALTH INC | $1,190,000 | -55.7% | 311,640 | -9.7% | 0.40% | -37.6% |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $1,004,000 | -7.6% | 88,185 | 0.0% | 0.34% | +29.7% | |
| MRSN | MERSANA THERAPEUTICS INC | $969,000 | +1.7% | 166,250 | 0.0% | 0.32% | +43.2% | |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $956,000 | -31.4% | 218,714 | +6.9% | 0.32% | -3.6% |
| NXGN | New | NEXTGEN HEALTHCARE INC | $946,000 | – | 90,657 | +100.0% | 0.32% | – |
| DYAI | New | DYADIC INTERNATIONAL INC | $935,000 | – | 179,795 | +100.0% | 0.31% | – |
| PGNY | Sell | PROGYNY INC | $913,000 | -26.0% | 43,100 | -4.0% | 0.31% | +4.1% |
| BCEL | Sell | ATRECA INC | $782,000 | -40.8% | 47,252 | -44.6% | 0.26% | -16.6% |
| MORF | New | MORPHIC HOLDING INC | $729,000 | – | 49,686 | +100.0% | 0.24% | – |
| IMVTW | New | IMMUNOVANT INC*w exp 12/18/2024 | $715,000 | – | 307,700 | +100.0% | 0.24% | – |
| KOD | New | KODIAK SCIENCES INC | $716,000 | – | 15,000 | +100.0% | 0.24% | – |
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $450,000 | – | 25,000 | +100.0% | 0.15% | – |
| ARAV | Sell | ARAVIVE INC | $441,000 | -67.1% | 76,514 | -22.1% | 0.15% | -53.8% |
| PRVB | New | PROVENTION BIO INC | $387,000 | – | 42,100 | +100.0% | 0.13% | – |
| RAPT | New | RAPT THERAPEUTICS INC | $304,000 | – | 14,298 | +100.0% | 0.10% | – |
| AMRN | New | AMARIN CORPORATION PLCspons adr new | $200,000 | – | 50,000 | +100.0% | 0.07% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $196,000 | – | 132,474 | +100.0% | 0.07% | – |
| SRRA | New | SIERRA ONCOLOGY INC | $151,000 | – | 15,395 | +100.0% | 0.05% | – |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $150,000 | – | 10,701 | +100.0% | 0.05% | – |
| MNLO | New | MENLO THERAPEUTICS INC | $61,000 | – | 22,913 | +100.0% | 0.02% | – |
| New | BELLICUM PHARMACEUTICALS INC | $58,000 | – | 12,272 | +100.0% | 0.02% | – | |
| MESO | New | MESOBLAST LTDput | $35,000 | – | 8,100 | +100.0% | 0.01% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.07% | – | |
| MTD | Exit | METTLER-TOLEDO INTERNATIONAL INCput | $0 | – | -400 | -100.0% | -0.08% | – |
| CMD | Exit | CANTEL MEDICAL CORPput | $0 | – | -7,300 | -100.0% | -0.12% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -43,433 | -100.0% | -0.14% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -9,588 | -100.0% | -0.17% | – |
| LOGC | Exit | LOGICBIO THERAPEUTICS INC | $0 | – | -125,836 | -100.0% | -0.22% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -282,520 | -100.0% | -0.22% | – |
| OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -264,581 | -100.0% | -0.26% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INCcall | $0 | – | -311,400 | -100.0% | -0.27% | – |
| OPK | Exit | OPKO HEALTH INC | $0 | – | -805,311 | -100.0% | -0.28% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -30,052 | -100.0% | -0.29% | – |
| XCUR | Exit | EXICURE INC | $0 | – | -452,792 | -100.0% | -0.31% | – |
| BEAT | Exit | BIOTELEMETRY INCput | $0 | – | -28,200 | -100.0% | -0.31% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -79,067 | -100.0% | -0.33% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -87,700 | -100.0% | -0.34% | – |
| BNGO | Exit | BIONANO GENOMICS INC | $0 | – | -1,210,821 | -100.0% | -0.36% | – |
| PHG | Exit | KONINKLIJKE PHILIPS NVput | $0 | – | -33,800 | -100.0% | -0.39% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTDcall | $0 | – | -219,100 | -100.0% | -0.42% | – |
| UROV | Exit | UROVANT SCIENCES LTD | $0 | – | -160,442 | -100.0% | -0.59% | – |
| PFNX | Exit | PFENEX INC | $0 | – | -232,626 | -100.0% | -0.61% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCput | $0 | – | -41,900 | -100.0% | -0.72% | – |
| ITGR | Exit | INTEGER HOLDINGS CORP | $0 | – | -44,679 | -100.0% | -0.86% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -37,781 | -100.0% | -0.97% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -36,632 | -100.0% | -1.00% | – |
| HRC | Exit | HILL-ROM HOLDINGS INC | $0 | – | -40,182 | -100.0% | -1.09% | – |
| MMSI | Exit | MERIT MEDICAL SYSTEMS INC | $0 | – | -150,000 | -100.0% | -1.12% | – |
| BEAT | Exit | BIOTELEMETRY INC | $0 | – | -160,015 | -100.0% | -1.76% | – |
| SNY | Exit | SANOFI SAsponsored adr | $0 | – | -170,977 | -100.0% | -2.04% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS INC | $0 | – | -24,776 | -100.0% | -2.22% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -204,705 | -100.0% | -2.29% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -186,000 | -100.0% | -2.88% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -44,935 | -100.0% | -3.53% | – |
| PFE | Exit | PFIZER INC | $0 | – | -380,874 | -100.0% | -3.55% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -147,022 | -100.0% | -3.97% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INCput | $0 | – | -1,946,800 | -100.0% | -15.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.